Suppr超能文献

结肠癌细胞系中SMAD4 - 209和SMAD4 - 213转录本及其各自启动子的失调。

Dysregulation of transcripts SMAD4-209 and SMAD4-213 and their respective promoters in colon cancer cell lines.

作者信息

Babic Tamara, Ugrin Milena, Jeremic Sanja, Kojic Milan, Dinic Jelena, Banovic Djeri Bojana, Zoidakis Jerome, Nikolic Aleksandra

机构信息

Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia.

Institute of Virology, Vaccines and Sera "Torlak", 11152 Belgrade, Serbia.

出版信息

J Cancer. 2024 Aug 6;15(15):5118-5131. doi: 10.7150/jca.98911. eCollection 2024.

Abstract

The pervasive role of alternative promoters in context-specific isoform expression and the importance of promoter choice over its level of transcriptional activity have been recently implied based on pan-cancer studies. We aimed to explore this phenomenon at the cellular level on the example of a major tumor suppressor SMAD4 in search of molecular mechanisms in colorectal cancer that could be exploited for novel biomarkers or therapeutic approaches. Multi-omics technologies, tools and functional assays were applied to analyze the transcripts expression and the alternative promoters' function of the SMAD4 gene in colon cell lines HCEC-1CT, HCT116, DLD-1, SW480 and SW620. High expression of the transcript SMAD4-213 emerged as a hallmark of colon cancer cells, while tools point to its possible additional role and potential for sponging miRNAs. Based on the observed dysregulation of SMAD4-209 and SMAD4-213 in malignant vs. non-malignant colon cells, we propose that their expression ratio might be a solid biomarker candidate for colorectal cancer detection. A differential pattern of the respective promoters' activity was observed that corresponds to the expression of transcripts, confirming the role of alternative promoters in context-specific isoform expression. The investigated promoters and transcripts harbor translational potential that should be further investigated.

摘要

基于泛癌研究,最近已暗示了可变启动子在特定背景下的异构体表达中的普遍作用以及启动子选择相对于其转录活性水平的重要性。我们旨在以主要肿瘤抑制因子SMAD4为例,在细胞水平上探索这一现象,以寻找可用于新型生物标志物或治疗方法的结直肠癌分子机制。应用多组学技术、工具和功能测定法来分析结肠癌细胞系HCEC-1CT、HCT116、DLD-1、SW480和SW620中SMAD4基因的转录本表达和可变启动子的功能。转录本SMAD4-213的高表达成为结肠癌细胞的一个标志,而工具表明其可能具有额外作用以及充当miRNA海绵的潜力。基于在恶性与非恶性结肠细胞中观察到的SMAD4-209和SMAD4-213的失调,我们提出它们的表达比率可能是结直肠癌检测的一个可靠生物标志物候选物。观察到各自启动子活性的差异模式与转录本的表达相对应,证实了可变启动子在特定背景下异构体表达中的作用。所研究的启动子和转录本具有翻译潜力,应进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/11310865/2ca460120eb9/jcav15p5118g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验